Back to Journals » Infection and Drug Resistance » Volume 19

Characterization of NDM-4-Producing Citrobacter amalonaticus Isolates from China

Authors Yan R, Lian X, Xu H, Li Y, Chen M

Received 12 December 2025

Accepted for publication 1 April 2026

Published 17 April 2026 Volume 2026:19 583174

DOI https://doi.org/10.2147/IDR.S583174

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Hazrat Bilal



Rong Yan,1 Xiang Lian,2 Hao Xu,3 Yaling Li,4 Meijuan Chen1

1Center for General Practice Medicine, Department of Infectious Diseases, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, People’s Republic of China; 2Department of Infectious Diseases, The Affiliated Xiangshan Hospital of Wenzhou Medical University; Xiangshan First People’s Hospital Medical and Health Group; Ningbo Fourth Hospital, Ningbo, People’s Republic of China; 3State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China; 4Department of Health Management Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

Correspondence: Yaling Li, Department of Health Management Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China, Tel/Fax +86-571-87784688, Email [email protected] Meijuan Chen, Center for General Practice Medicine, Department of Infectious Diseases, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, People’s Republic of China, Tel/Fax +86- 571-87666666, Email [email protected]

Objective: The aim of this study was to investigate the genomic features of carbapenem-resistant Citrobacter spp. carrying blaNDM-4 on a novel IncFII-116 plasmid.
Methods: Carbapenem-resistant Citrobacter spp. isolates were collected from diarrheal inpatients. Antibiotic susceptibility testing was routinely performed. Whole-genome sequencing and bioinformatic analyses were conducted on the isolates with blaNDM-4 gene.
Results: Whole- genome sequencing was performed on the two C. amalonaticus isolates carrying blaNDM-4. Whole-genome analysis revealed that pL5091_blaNDM-4 and pL5094_blaNDM-4belong to a new type of plasmid (IncFII-116) with lengths of 87124 bp and 87952 bp in two C. amalonaticus, respectively. Moreover, blaNDM-4 was encoded in the trpF-ble-blaNDM-4-IS15 cassette array.
Conclusion: We identified a novel IncFII-116 plasmid carrying blaNDM-4 in C. amalonaticus for the first time, raising concerns about the emergence of carbapenem-resistant Citrobacter spp.

Keywords: carbapenem-resistant, C. amalonaticus, IncFII-116, NDM-4, whole-genome sequencing

Introduction

Citrobacter spp. is a common zoonotic pathogen comprising 11 species.1 Various species of Citrobacter spp. may cause infections, including diarrhea, sepsis, meningitis, or respiratory and urinary system infections in neonates, the elderly, and immunocompromised hosts.2 Although the majority of cases are sporadic, mortality associated with invasive Citrobacter spp. infections is high.3,4

A recent increase in multidrug resistance among Citrobacter spp. has been reported.4 Previous studies have demonstrated that Citrobacter spp., especially C. freundii, harbor carbapenemase genes and contribute to a high proportion of carbapenem-resistant Enterobacterales, representing an emerging infection control and public health challenge.5–7 Different carbapenemase genes, such as blaNDM-1, blaKPC-2, blaIMP-4, blaVIM-2 and blaOXA-48, have been identified in Citrobacter spp.5 In addition, several specific plasmids and other genetic mobile elements for carbapenemase gene carriage have been identified, such as IncN[pMLST15] for KPC-2 and TnAS3 for NDM-1.5,8 Among plasmids harboring blaNDM, in Enterobacteriaceae, IncX3 was predominant, followed by the IncFII type.7 Several studies have reported different carbapenemase genes and transmission mechanisms in C. freundii, C. koseri, and C. braakii.5,8 However, genomic analyses of NDM-producing C. amalonaticus have been limited. In this study, the genomic characterization of two carbapenem-resistant C. amalonaticus isolates harboring blaNDM-4 were analyzed.

Methods

Collection and Identification of Bacterial Strains

Fecal samples (1.0 g) from inpatients with diarrhea were cultured on MacConkey agar supplemented with 2 mg/L meropenem for 18–24 h at 37°C from 2016 to 2023 at The First Affiliated Hospital, Zhejiang University School of Medicine. Isolates were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker, Bremen, Germany). Citrobacter spp. isolates were collected for further analysis. Carbapenemase-encoding genes (blaNDM, blaKPC, blaIMP, blaVIM and blaOXA-48) were tested using PCR.9

Antibiotic Susceptibility Testing

The MICs of 18 antibiotics were determined according to Clinical and Laboratory Standards Institute (CLSI) recommendations. The results were interpreted in accordance with the guidelines of the Clinical and Laboratory Standards Institute (CLSI) guidelines.10

Whole Genome Sequencing (WGS) and Bioinformatics Analysis

Genomic DNA was extracted using the FastDNA SPIN Kit for Soil (MP Biomedicals, United States) and sequenced using Illumina HiSeq 2000 (Novogene Bioinformatics Technology Co., Ltd., Beijing, China) and Oxford Nanopore Technologies platform (Oxford Nanopore Technologies, Oxford, UK), Complete genome sequences were generated by performing a hybrid assembly of short-read and long-read sequences using Unicycler v0.4.8.

The Whole Genome Shotgun BioProject for the included isolates was deposited under accession number PRJNA1118925. The plasmid sequence was hosted in the corresponding BIGSdb database under accession number IncFII-116.

The antimicrobial resistance genes were identified using ResFinder version 2.1 (http://cge.cbs.dtu.dk/services/resfinder). Plasmid Finder v. 1.3 was used to identify the plasmid incompatibility type.11 All sequenced genomes were annotated using Prokka.12 The Pyani and Python3 modules calculate the average nucleotide identity (ANI) and related measures for species comparisons (https://github.com/HuttonICS/pyani). Plasmid alignment was performed and visualized using BLAST ring image generator (BRIG) software.

Results

Characteristics of the Carbapenem-Resistant Citrobacter Spp

Forty-two carbapenem-resistant Citrobacter spp. were identified, including 32 C. freundii, three C. koseri, three C. braakii, two C. amalonaticus, and two C. youngae.

Among C. freundii isolates, PCR revealed that 19 isolates carried blaNDM, four isolates carried blaKPC, one isolate carried blaIMP, one isolate carried blaVIM and one isolate carried blaOXA-48 (Supplementary Table S1). In addition, blaKPC coexisted with blaNDM in three C. freundii isolates. All C. koseri isolates harbored blaKPC and C. amalonaticus harbored blaNDM-4.

Antimicrobial Susceptibility

Two NDM-4-producing C. amalonaticus isolates (L5091 and L5094) were resistant to multiple antibiotics (Table 1).

Table 1 Antimicrobial Drug Susceptibility Profiles

Genetic Characteristics of NDM-4-Producing C. amalonaticus

Strains L5091hy and L5094hy had the highest ANI values compared to the type strain of C. amalonaticus (GCA_001558935.2) (Figure S1). A circular chromosome and several plasmids were confirmed in two C. amalonaticus isolates (L5091hy and L5094hy) by whole-genome sequencing. Plasmids pL5091_blaNDM-4 and pL5094_blaNDM-4 are novel IncFII-116 plasmids. The lengths of the two plasmids were 87124 bp and 87952 bp, respectively. The average GC content of the two plasmids was 53.6% and 53.6%, respectively.

The genetic structures of pL5091_blaNDM-4 and pL5094_blaNDM-4 are similar (Figure 1). The genetic environment for blaNDM-4 in the two C. amalonaticus isolates was trpF-ble-blaNDM-4-IS15. However, it is of note that a large fragment of recombination in IS15 were identified downstream of blaNDM-4 in pL5094_blaNDM-4.

A diagram showing genomic maps of pL5091_blaNDM-4 and pL5094_blaNDM-4 plasmids with related plasmids.

Figure 1 Major structural features and comparison of NDM-encoding plasmids. Genomic map of the blaNDM-4 producing pL5091_blaNDM-4/pL5094_blaNDM-4 plasmids with three closely related plasmids (CP043383.1, ON209143.1, ON964513.1). (A) pL5091_blaNDM-4; (B) pL5094_blaNDM-4. ORFs are portrayed by arrows and colored according to their putative functions. The alignment of the plasmids was performed and visualized by BLAST ring image generator (BRIG) software.

Discussion

The continued increase in the prevalence of multidrug-resistant Citrobacter spp. poses a global health security threat.3,5 The present and previous studies have demonstrated C. freundii is the predominant epidemic isolate.5,6 The blaNDM gene is commonly detected in carbapenem-resistant Citrobacter spp. In addition, blaNDM-4 in two C. amalonaticus isolates were first identified in this study.

A previous study reported C. freundii accounted for 83% of Citrobacter spp., which was higher than our result (76.2%).5,13 This difference may be because the strains in our study were isolated only from fecal samples. As previously described for C. freundii, the transmission mechanisms of blaNDM-1-, blaVIM-1-, and blaOXA-48-carrying plasmids were IncF, IncN, and IncM1, respectively.14 Notably, blaNDM was the most frequent carbapenemase detected in C. freundii, which differs from other strains in France.13 Both local and global carbapenem-resistant Citrobacter spp. are genetically diverse.6 In addition, several earlier studies have reported the co-production of two or three carbapenemases, such as KPC-2 plus NDM-1, KPC-2 plus VIM-2, VIM-1 plus OXA-48, or KPC and NDM plus SHV, in Citrobacter spp. isolates.5,8,15,16

C. amalonaticus is seldom isolated from fecal or urine samples. A study described the coexistence of blaNDM-1 and mcr-1-like genes in C. amalonaticus.17 To the best of our knowledge, this is the first report of C. amalonaticus harboring blaNDM-4, significantly extends our understanding of the structural diversification of plasmids. These results highlight the necessity of continuously monitoring the dissemination of carbapenem-resistant Citrobacter spp. in the clinical setting.

The most prevalent plasmids carrying blaNDM are IncX3, IncFIB, IncFII, and IncC types.18 Here, we report two carbapenem-resistant C. amalonaticus isolates in China, carrying a novel IncFII-116 plasmid containing blaNDM-4, which is relatively close to IncFII. Therefore, the comprehensive resistance surveillance of Citrobacter spp. should be further strengthened.

Conclusion

Here, we characterized the first IncFII-116 plasmid carrying blaNDM-4 in two C. amalonaticus isolates from China. The genetic environment of NDM-4 has been elucidated, highlighting the need to monitor the dissemination of carbapenemase-encoding genes and plasmids.

Data Sharing Statement

This Whole Genome Shotgun BioProject for the two Citrobacter amalonaticus isolates has been deposited in GenBank under the accession number PRJNA1118925. The plasmid sequence was hosted in the corresponding BIGSdb database under accession number IncFII-116.

Ethics Approval and Consent to Participate

This study was retrospective in nature, so informed consent was waived by the Clinical Research Ethics Committee of The First Affiliated Hospital, Zhejiang University School of Medicine. Patient treatment information was de-identified and complied with the Declaration of Helsinki. All experiments strictly followed relevant guidelines and regulations, and the ethical protocol was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (no. 2018-752).

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

This work was supported by the Natural Science Foundation of Zhejiang Province (grant number LQ24H260001), Medical Science and Technology Project of Zhejiang Province (grant number 2023KY721), and Department of Health of Zhejiang Province (grant number 2023XY037).

Disclosure

The authors report no conflicts of interest in this work.

References

1. Brenner DJ, Grimont PA, Steigerwalt AG, Fanning GR, Ageron E, Riddle CF. Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov. Citrobacter youngae sp. nov. Citrobacter braakii sp. nov. Citrobacter werkmanii sp. nov. Citrobacter sedlakii sp. nov. and three unnamed Citrobacter genomospecies. Int J Syst Bacteriol. 1993;43(4):645–6. doi:10.1099/00207713-43-4-645

2. Doran TI. The role of Citrobacter in clinical disease of children: review. Clin Infect Dis. 1999;28(2):384–394. doi:10.1086/515106

3. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Bacteremia due to Citrobacter species: significance of primary intraabdominal infection. Clin Infect Dis. 1996;23(3):543–549. doi:10.1093/clinids/23.3.543

4. Lee R, Choi SM, Jo SJ, et al. Clinical characteristics and antimicrobial susceptibility trends in Citrobacter Bacteremia: an 11-year single-center experience. Infect Chemother. 2019;51(1):1–9. doi:10.3947/ic.2019.51.1.1

5. Yao Y, Falgenhauer L, Falgenhauer J, et al. Carbapenem-resistant Citrobacter spp. as an emerging concern in the hospital-setting: results from a genome-based regional surveillance study. Front Cell Infect Microbiol. 2021;11:744431. doi:10.3389/fcimb.2021.744431

6. Babiker A, Evans DR, Griffith MP, et al. Clinical and genomic epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a tertiary health care center over 2 decades. J Clin Microbiol. 2020;58(9):e00275–20. doi:10.1128/JCM.00275-20

7. Yoon EJ, Kang DY, Yang JW, et al. New Delhi Metallo-Beta-Lactamase-producing Enterobacteriaceae in South Korea between 2010 and 2015. Front Microbiol. 2018;9:571. doi:10.3389/fmicb.2018.00571

8. Li Y, Fang C, Qiu Y, Dai X, Zhang L. Genomic characterization of a carbapenem-resistant Citrobacter freundii cocarrying bla(KPC-2) and bla(NDM-1). J Glob Antimicrob Resist. 2022;29:289–292. doi:10.1016/j.jgar.2022.04.014

9. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.002

10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 34th informational supplement 2024. Available from: http://www.clsi.org/. Accessed February 2024.

11. Carattoli A, Zankari E, García-Fernández A, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–3903. doi:10.1128/AAC.02412-14

12. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–2069. doi:10.1093/bioinformatics/btu153

13. Arana DM, Ortega A, González-Barberá E, et al; Spanish Antibiotic Resistance Surveillance Programme Collaborating Group. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2. J Antimicrob Chemother. 2017;72(12):3283–3287. doi:10.1093/jac/dkx325

14. Biez L, Bonnin RA, Naas T, Dortet L. Characterization of VIM-1-, NDM-1- and OXA-48-producing Citrobacter freundii in France. J Antimicrob Chemother. 2022;77(4):1200–1202. doi:10.1093/jac/dkac005

15. Ma J, Xu R, Li W, Liu M, Ding X. Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying bla(OXA-48) and bla(NDM-1). Ann Clin Microbiol Antimicrob. 2024;23(1):38. doi:10.1186/s12941-024-00699-y

16. Luo X, Yu L, Feng J, et al. Emergence of extensively drug-resistant ST170 Citrobacter portucalensis with Plasmids pK218-KPC, pK218-NDM, and pK218-SHV from a Tertiary Hospital, China. Microbiol Spectr. 2022;10(5):e0251022. doi:10.1128/spectrum.02510-22

17. Faccone D, Albornoz E, Tijet N, et al. Characterization of a multidrug resistant Citrobacter amalonaticus clinical isolate harboring bla(NDM-1) and mcr-1.5 genes. Infect Genet Evol. 2019;67:51–54. doi:10.1016/j.meegid.2018.10.020

18. Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z. NDM Metallo-β-Lactamases and their bacterial producers in health care settings. Clin Microbiol Rev. 2019;32(2):e00115–18. doi:10.1128/CMR.00115-18

Creative Commons License © 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.